yourstate.us
21 CFR 862.1700

§ 862.1700 Total thyroxine test system.

United States · 21 CFR — Food and Drugs · Status: effective

Get this as JSONEmbed this
Cite this
Citation
21 CFR 862.1700, § 862.1700 Total thyroxine test system, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/89190
Permanent ID
ys:prov:89190@1
SHA-256
b894affc2f11ecfadafd5ee70dbf86ea98cf899af82b5317584dd5c149b7a783

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Identification. A total thyroxine test system is a device intended to measure total (free and protein bound) thyroxine (thyroid hormone) in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of thyroid diseases. (b) Classification. Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.